Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...

More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...

People living with HIV who smoke are currently more likely to die from lung cancer than from HIV-related causes. Two cancer ...

Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...

More than 230 people became infected with HIV in Indiana, worsened by delayed action from former Gov. Mike Pence. Experts and ...

The truth is, the existence of Community Health Workers (CHWs) like Muhammad Fitri remains largely unknown to the public. They work with people at the margins of society — many living with HIV/AIDS in ...

Richard says it took two days for a qualified interpreter to arrive and explain he had been given the all-clear. "If an ...

HOOKIPA Pharma Inc. (OTCID: HOOK, 'HOOKIPA”) today announced the completion of the sale of its assets related to HOOKIPA’s HB-400 program and certain of its assets related to HOOKIPA’s HB-500 program ...

Researchers used cryo-EM to study how the HIV enzyme integrase arranges in 3D to slip its DNA into the host genome and pack ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

Gilead stock slumped late Thursday on soft product sales and lighter-than-expected revenue from its newcomer HIV prevention ...

The NHS has secured a confidential discount on the treatment, which is listed at around £7,000 per patient per year, from its ...